4th$YEAR$Professional$Pharmacy$ Placement$Semester$1:$DRUG$LIST$2013$$
|
|
- Brent Grant Warner
- 6 years ago
- Views:
Transcription
1 4th$YEAR$Prfessinal$Pharmacy$ Placement$Semester$1:$RUG$LIST$2013$$ Guide:Majrityfthedruglistremainsthesameeachyear,withusuallynlynertwdrugsbeing different.itisimprtanttknwtheindicatin,dse,adverseeffects,mdeftheactin(briefly), precautins(smepints),interactinsandcunsellingpints.hspitalplacementfcusesmren mnitringanddsesfrcmmnindicatins,whilethecmmunityplacementwillfcusmren cunselling. Cntents Alendrnate Page24 Allpurinl Page56 Amidarne Page711 Amldipine Page1213 Celecxib Page1417 Clpidgrel Page1819 abigatran Page2022 igxin Page2326 iltiazem Page2729 Enxaparin Page3032 Fluticasne Page3335 Frusemide Page3638 Gliclazide Page3940 Glyceryltrinitrate Page4143 Heparin Page4447 Hydrcrtisne Page4853 Insulin Page5458 Irbesartan Page5960 IssrbidemnnitratePage6162 Mesalazine Page6367 Metfrmin Page6870 Metprll Page7174 Methtrexate Page7579 Prednislne Page8081 Ramipril Page8285 Salmeterl Page8688 Simvastatin Page8992 Titrpium Page9395 Verapamil Page9699 Warfarin Page100103
2 Terms: Pagetsdisease=iswheretheremdellingprcess(breaking&buildingfbne)isdisturbedcausing excessivebneresrptinbysteclastsandadisrganisedcmpensatryincreaseinbnefrmatin. Gettingweakdefrmbnesintheskeletn,leadingtbnepain ONJ(stenecrsisfthejaw)=getbnenecrsisduetbldvesselsaredestryede.gprral hygieneandbac.theischaemicbnedesn tgetridfbysteclastasthebisphsphnateinhibitsit,s itkeepsgrwing. Bisphsphnates Alendrnate Tx: Pagetsdiseasefbne1 st lineisbisphsphnaterelievesthepain&breakdwn Preventinandtreatmentfsteprsis(incpstmenpausal&crticsteridinduced)=1 st line sagefrm:tab:adrnat,alendr,ensate,fsamax,ossmax Cmb:(alendrnate70mg,clecalciferl(vitamin3)70/140mg):rnalenPlus,FsaamaxPlus se: Pagetsdisease=40mgd(frupt6mnths) TxsteprsisinM&pstmenpausalF=10mgdr70mgnceawk Preventinfpstmenpausalsteprsis=5mgd. txandpreventinfcrticsteridinducedsteprsis=5mgd;10mgdfrpstmenpausalwmen ntreceivingestrgen MOA:slwsdwnbnebreakdwn(byinhibitsteclast)andallwsbnetrebuildintnrmalbnes a/e; Cmmn:NVH,+hypcalcaemia,musculskeletalpain(rarelybesevere) IV:allergicrxn,flulikesx Infreq:(quiteirritatinghencewhentakeralgetSI:esphagitis,ersin/ulcerinesphageal Rare:renalimpairment,ONJ ONJ:needbecarefulfhxdentalsurgery,prdentalhygiene.It sriskislwerinral PK:givenralaftervernightfastrIV.Haslngt1/2inbneTyrsasenzymeresistant Needvernightfastasithaslwabsrptalready&fd/drinks itmre ShuldgiveCa2+&vitsupplementswithuseifdietinadequateasneedCatbuildthematrixfirst Precautin: ONJ:OstenecrsisfthejawCnsiderdentalassessmentbefreuse,espifhaveriskfactrslike cancer,chemtherapy.prralhygiene, CancausedeteriratinfrenalfunctasitsExcretedunchangedmainlyviathekidney Aviduseinsevererenalimpaired UpperGIcnditins(egdysphagia,gastritis),usewithNSAIs increaseriskfesphagealadverse effects. C/i: hypcalcaemia asa/eduetinhibitsteclastsca2+cantbereplacedinbldfrmbne Inabilitytstandrsituprightfratleast30minutes Oesphagealdisrders(activeesphagitis,esphagealulceratin,swallwingdifficulty) Preg&b/faviduseasndata.CatB3.Tx:useCalciumtab Interactins:
3 Ca,Fe,Mge.gantacid,supp it absrptinfralbisphsphnates.tx:dnttakewithin2hursf takingabisphsphnate(atleast30minutesafteralendrnateribandrnicacid). alendrnate+nsais: gastriculcerwithnsai.tx:avidcmbrmnitr Mnitring; Efficacy:Bne&a/e:BM,Ca2+lvls,Vit,Xrays, alkalinephsphatase(frpagetsdisasisbnemarkerfrbnefrmatin)=madebysteblast. ALP, bneturnver.e.ginpagetdis ALP a/e:crclascauserenalimpairment " dentalassessment:onj " heartburn,dysphagia(painnswallw)=esphagitis Cunselling:IARL :Swallwwhletabletinthemrningwithafullglassfplainwaternanemptystmach,sb/fany fdrdrink,andstayuprightfratleast30minduringthistime.uringthis30mindnteat/drink, nlytapwater.(caneatafter30min) Plainwaterntmineralwaterasdrink/fdcan absrptasitcaninteractwithaltfthings. Swallwwhlesdesn tcausemuthulcerandwatertmakesureitdesn tgetstuck Stayupright tensureitdesn tgetstuckncauseirritatintthrat (I) nttakeantacids,calcium,irnrmineralsupplementswithin30minutesfalendrnateas theymayinterferewithitsabsrptin.(asprabsrptin.nbtherbisphsphnateiswait 2hrsb/ftakesupplements) A: Tellyurdentistandhealthprfessinalyuaretakingthisdrugasthereareraredental cmplicatinsitmaycause.henceimprtantthavegdralhygiene Tellyurdctrifyuhaveseverepaininyurbnes,jintsrmuscleswhiletakingthis medicine.includingjawpainrdentalprblemse.gtthache R:Stptabletsandseeyurdctrimmedifyuhavepainnswallwing,rnewrwrsening heartburngiirritatin L: NOTES Lwweightbearingexercises MakesureuhaveadequatecalciumindietifntenughgiveCa,vitsupplements(tbe takenatadifferenttimefdaytralbisphsphnatee.gatnightandalendrnateinmrning) " AdeqdietintakefCa2+:1300mgfrmen>70y,pstmenpausalF,teenage12T18y 1000mgfralltheradultes(incpreg/bf),child9T11y Bisphsphnatesmay AF.Alendrantewasassciatedwithitbutneedfurtherresearch Lwenergyfemral(thigh)fracturenlngtermuse(asptentiallymakebnesbrittleeventhu BM)butrareandntsureifcause.Hweverbenefitfdrug>risk (BM) T-screis the # f S away frm the mean BM f an adult aged 30 years T-scre Interpretatin -1 r higher nrmal between -1 and -2.5 stepenia -2.5 r lwer steprsis
4 AspirinAVOIASPIRININGOUTaswrsensitduetsalicylatecntentinhibitskidneytsecreteurate. Occursevenatanalgesicdses. Ifatlwdseasanticagcntuseasbenefitsutweighrisk FASTING,HYPOTHYROIISM,ALCOHOL= Urateexcretin (MstAlchl(excludingwine)hashighpurinecntentduettheyeast) Cyclsprineinhibitstransprterfuricacidusedfrexchangeinkidneyfrexcretin&als breakdwnfcells. Nictinicacid(niacin/vitb3)Thighdsecauseskidneytexcreteitratherthanuricacid rug_drug: Amxycillin(Pc)/ampicillin+allpurinl:riskfskinrash AzathiprineandmercaptpurineAllpurinlwill theirmetablismbyinhibitingxanthinexidase, itscncentratinbmsuppressin(severebmtxicity).txaviduseifpssiblerreduce Azathiprine/mercaptpurinedset1/4r1/3fnrmal allpurinl+thephylline:highdseallpurinlwill thephyllinecnc riska/e.tx:mnitr thephyllinecncentratinandfradverseeffects;decreasethephyllinedseasneeded. Mnitring #gutattacks,#jintsaffected Uricacidlvls:nteHyperuricaemiaisaRISKFACTORbutOESNOTmeanthatpatientwith hyperuricaemiawillhavegut rug:fbc,lft Gis/e,allergicrxn Renalfx:tadjustAllpurinldse cunselling Takethismedicineshrtlyafterfdtreducethepssibilityfstmachupset.(labelBtakewith fd) AThismedicinemaymakeyufeeldizzyrdrwsy;dntdriverperatemachineryifyuare affected.(label12) R_Ifyudevelparash,swllenlipsrmuth,persistentfeverrsrethrat,stptakingallpurinl andtellyurdctrimmediately. Rash,swllenlip=allergicrxn. stillreferifgetrashasculdbeallergicrxn persistentfeverrsrethrat= WBCfrmBMsupp L Makesurethatyudrinkltsffluidsduringtreatment(atleast2Lperday) ReducealchlintakeESPECIALLYBEER,iet:(decrease)highpurinecntente.gSeafdAnimal liver,kidney,pancreas,weightlss Practicepints: IfrenalfailurereduceallpurinldseandPROBENECIEISINEFFECTIVE stpallpurinlifrashdevelps,therearethersignsfallergy,liverfunctinisabnrmal,rbld dyscrasiasccur Ntes: prbenecidislesseffectivethanallpurinlbutcanbeaddedtallpurinlifntwrking/severe
5 Terms Refractryperidamuntftimeittakesfranexcitablemembranetbereadyfrasecndstimulus Intrpe=cntractinsfheart +veintrpiceffect= frcefcntractin Chrntrpic=HeartRate,+veChrntrpiceffect= HR SVT:atrialtachycardiaandarrhythmiasarisingfrmtheatriventricular(AV)junctin sicksinussyndrme=allheartrhythmdisrdersthatisduetsinusnde(pacemaemaker)malfunctine.gsinus bradycardia,sinuspausesrarrest(whenthepacemakerstpswrkingfrperidsftime) 2 nd /3 rd degreeblcks=(aavblcksimpulsegeneratedinthesandeintheatriumdesntprpagatetthe ventricle) Heartblckisaprblemthatccurswiththeheartselectricalsystem.Thissystemcntrlstherateandrhythm fheartbeats.heartblckccursiftheelectricalsignalisslwedrdisruptedasitmvesthrughtheheart. Firstdegreeheartblckmayntcauseanyseveresymptms. Secnddegreeheartblckmayresultintheheartskippingabeatrbeats.Thistypefheartblckalscanmake yufeeldizzyrfaint. Thirddegreeheartblck(cmpleteblck)limitstheheartsabilitytpumpbldttherestfthebdy.This typefheartblckmaycausefatigue(tiredness),dizziness,andfainting.thirddegreeheartblckrequires prmpttx,e.gapacemaker,becauseitcanbefatal. Amidarne(likethyridhrmnestructure) Tx Treatment&Prphylaxisfseveretachyarrythmias(fastirregularheartbeat)refractry(can tbe managed)tthertxe.gaf,ventriculartachycardia,andsvt atrialfibrillatin(af) " cardiversin=useasmaintenanceafternsr 2 nd lineduetit sa/e.1 st line=flecainide " rhythmcntrl=cnvertthearrhythmiatnrmalsinusrhythm(nsr)bydrug 1 st lineis flecainidenamidarane ventriculartachycardia parxysmalsupraventriculartachycardia(svt)prphylaxis.itisregularfasthrthatbeginsand endssuddenly&riginatesfrmmycardium(hearttissue)ratherthanventricles acutecardigenicpulmnaryedema=ifthepatientisinafwithrapidventricularrateanditis thughttbeacntributingfactrtprcardiacutput,useit(iv) sagefrms tablets(arataccrdarnerithmikcardinrm) IV(Crdarne) se(trytuselwestdsenecessarytcntrlarrhythmia) Adult Oral(nnurgentcasesstartwithmaintenancedse.Omitladingdse) " Lading:200mgtdsfr1weekfllwedby200mgbdfr1week " Maintenance:100_400mg1d IV(seekspecialistadvice) " Emergency:150T300mgver1T3minutes(mnitrclinicalsigns+ECGclsely) " Lading:5mg/kgver20minT2hurs " Maintenance:15$20mg/kgver24hurs(max1.2gin24hrs). BeginraltreatmentASAPverlappingralandIVtreatmentbyupt2days MOA:Itactsbyblckingptassiumrectifiercurrents(IK)thatreplarisetheheartprlngingAP& refractryperid.apcannlybegeneratedncesdiumchannelahsreturedtrestingstatenceslws cnductinslwshr. ecreases sinus nde autmaticity,ecreases ventricularcnductin ClassIIIantiarrhythmicagent ecreasesaandavcnductin Prlngsphase3fthecardiacactinptential(thereplarizatinphasewherethereisnrmally decreasedcalciumpermeabilityandincreasedptassiumpermeability)
6 Mildbetablckereffects **A/e cmmn: GI:NV,anrexia,tastedisturbances(lssftast,metallictase),cnstipatin, Pulmnarytxicity.E.gdrypersistentcugh,SOB.(canturnintpneumnitis,brnchitisinfect)2 types: " Acuteinflameflungs=(Canccurearlyrlate)isReversibleifdrugiswithdrawnearly.May respndtcrticsterids " Chrnicfibrsisflungs=excessfibruscnnectivetissue(fibrsis)inthelungs,duet prlngedexpsure&islessreversible Skin:phtsensitivityBlue_Greyskindiscluratin, hyper/hypthyridismduetidinecntentfdrugcancause " Occurmainlyinfirst2years.Canccurevenwhenhavestppedamidarnefrmnthsdue tlngt½ Visualprblems:Crnealdepsits,blurredvisin " Reversiblebenignmicrdepsitsncrneaccurinmstpatientsbutrarelyaffectvisin (phtphbia,visualhalesmayccur) " Stpamidarneifpticneurpathyrneuritis(inflamfnervese.gpain)ccurs Neurtxicity(tremr,ataxia(lackfmusclecrdiantine.gdrunk),paraesthesia(pins&needles), peripheralneurpathy,limbweakness) Sleepdisturbances:nightmares,vivddreams Transientelevatinfliverenzymes Infreq: AVblck,arrhythmia bradycardia Rare Allergicrxn,alpecia Hepattxicity(aswhereitisstredandmetablised)e.ghepatits Thrmbcytpenia Heartfailure Opticneurpathy **Txicity:Blue_Greyskindiscluratin,eyetxicity,lungtxicity,heart_severebradycardia, hepattxicity Amidarne txicity frm prlnged use f the medicine. Amidarne is a fat sluble drug, it gets distributed t and stred in many different tissues f the bdy and has lng t ½. Strage is primarily in fat, muscle, liver, lungs, and skin, while its effects are als seen n thyrid and eyes in additin t heart. Its txicities als affect these rgans. Precautins Thyriddysfunctinincreaseriskfhyprhyperthyridism Lungdiseaseifgetpulmnarytxicityitisharderfrthemtrecver Electrlytedisturbances(hyper/hypkalaemia,hypmagnesaemia)increaseriskfarrhythmia, crrectbefrestartingtreatment *Hepaticimpairmentdecreasedmetablismaccumulatinandhepattxicity.itismetablisedby liver
7 Eplerenne(aldsterneantagnist)andriskfitsadverseeffectse.g.hyperkalaemia;TxLimit eplerennedset25mgdandmnitrptassiumcncentratinandclinicalsignsandadjustdse Chlestyramine BindstamidarneinGITdecreasingitsabsrptin Takeamidarne>1hrbefrechlestyraminer4T6hursafter Mnitramidarnecncentratinandclinicalrespnseandadjustdse Simvastatin Amidarneincreasesriskfmypathyrrhabdmylysiswithsimvastatin Usealternativestatinifpssible(e.gpravastatin) Ifcmbinatincanntbeavided,uselwesteffectivedsefsimvastatin(nt>20mgdaily) Mnitrfradverseeffectsandmeasurecreatinekinase(CK) **Mnitr Therapeuticmnitring:TRis12.5mg/L(1.64micrml/L). Maxeffectfdsagechangeisn tseenfr13mnthsrmre.cuzfitslngt½(13mnths) Befrestarting(thendq6mnts) Baselineclinicalstatus Serumelectrlyese.gK+riskfarrthymia Thyridfx,Liverfx(causehepattxicity),Lungfx(includingchestXray) Riskfthyridfunctinabnrmalitiesandliverdamagepersistfruptayearafter stppingtreatment;cntinuemnitring ECG Other: FBP:causethrmbcytpenia Eyeexam Ifdyspnea(SOB)rnnprductivecughdevelp(indicatepulmnarytxicity)perfrm chestxrayandlung(pulmnary)fxtestsasapandmnitrclsely Cunsel takewithfdtmingia/e A TelldctrifdevelpSOB,drycugh,prblemswithvisin,weightlss,muscleweaknessr wrseningfheartprblems (label8)avidsunexpsure,whereprtectiveclthingandsunscreen(spf30+) " asamidarnecausesphtsensitivity (label18)avidgrapefruitjuiceandtelldctriftakinganytherdrugs " Grapefruitjuiceinhibitmetablismfamidarnetxicity (label5)askurdcrpharmacistb/fusingthermedincotcrhealthprducts yu llneedregularbldtests,ecg,chestxrayswhiletakingthisdrug Extrainf Amidarneistheleastnegativelyintrpicantiarrhythmicandisusuallywelltleratedinheart failure Amidarnehasseriusadverseeffectsincludingptentialtwrsenarrhythmia;theseareslwt reslveafteritisstpped(verylnghalflife). Fatslublewithlnghalflife Resemblesthyrxinecancausethyridprblems.EachAmidarne200mgtabhas75mgf idine
8 BPlvls (NrmalBP=<120/80mmHg) +20/10(mild)HTN= 140/90 +20/10(mderate 160/100) +20/10(severe 180/110) Hyp=<90/60 Target: Pplw/diabetes,CV,kidneydis:<130/80( 10/10frmHTN) Pplw/severekidneydis(prteinuria> 1g/day)=<125/75(5/5frmabve) Everyneelse<140/90(HTN) Amldipine-:-Calciumchannelblcker Tx: Hypertensin pulmnaryhypertensin angina(stable) ACS(acutecrnarysyndrme)=recurrentepisdesf ischaemicchestpain Raynaudphenmenn=extremitiesffingers/tesBVIs cnstrictedcausingischemia sagefrm:tablets Aml,Nrdip,Nrvapine,Nrvasc,Ozldip amldipine/atrvastatin=caduet,cadatin se:all1d Adult,child>6years=initially2.5 5mgd,increasever1 2weekstamaxf10mg1d.i.e2.5_ 10mgd Child<6years,initially mg/kg1d,increasever1 2weekstamaxf0.4mg/kgr10mg1 difrequired.i.e0.1mg/kg_0.4mg/kg Elderly,hepaticimpairment=initially2.5mg1d MOA:inhibitsthevltageTgatedLTtypeCa2+channelinvascularSMarteriesblckingCa2+insentering causingvascularsmrelaxatin resultinvasdilatin aresabutmreptentscancausereflextachycardia$aslwbpactivatesbarrecepcausingcns activitywhich BPby HR a/e:cmmn:causesvasdilatinheadache,flushing,dizzy,fatigue peripheraledema duetvasdilate infreq:hyptensin,reflextachycardia,dyspepsia(gis/e),cnstipatin,pulmnaryedema rare:parkinsnism,cerebralandmycardialischaemia(fllwingexcessivefallinbp) interactins: drugsthat BPe.gSterids,NSAI,raldecngestants,COC, drugsthat BPlpdiuretic cyclsprin+amldipine=amldipinemay cyclsprincncriskftxicity;txmnitrcyclsprin cncandfra/e&decreasecyclsprindseifnecessary. mnitr: BP,HR(heartrate)frreflextachycardia LFT=frhepaticimpairment treducedse s/e=dizzy,headache,edema cunsel: : C&A:Label#9dn tstptakingitabruptly=causeafastheartrateangina.therefrereduceslwly ver12wks A C&A: Label12:thismedaffectmentalalertness ifaffecteddntdrive =cancausedizzy Cmmns/e:izzyflushingheadachetired,swllenankle(edema),thisisduetthedilatinfBV frmthemedicaitn izzy,headacheusuallygetsusetit.justtimefrbldtadjust
9 Celecxib-- Tx RA=autimmunedisthatcauseschrnicsystemicinflam.Wheretissuesthatlinejints (synvialmem)areattackedbywnimmunesystemàcausesswelling,pain,stiffnessin jints&jintdamage OA=Ostearthritisisadegenerativejintdiseasewherethecartilageisbrkendwn Ankylsingspndylitis=diseasewhichcausesinflammatinandpaininthespine(spineals calledspndylitis).causesunknwnbutprbduetgenes Painduetinjury(pstperative,musculskeletalrsfttissuee.gjintpain)r dysmenrrhea(perid) sagefrms 100mgand200mgCapsules:Celebrex se(nte:riskfcardivasculara/eisdserelated;sntuse>200mgdlngterm riskf CVevents) OA,Ankylsingspndylitis=upt200mgdin12divideddses RA=100mgbd.(Maybeincreasedt200mgbd(shrtterm)) Peridpain,Pain(pstperative,musculskeletalrsfttissue)=400mgdnthefirst day,then200mgncertwicedailyifneeded;max5daystreatment. (ntefrpain(pstperative,musculskeletalrsfttissue)the400mgdhasbe giveninasingledsehileperispaincanbein10r2dses) 400mgdn1 st day,then200mgdrbdrpn.max5daystx Mderatehepaticimpairment Startathalftherecmmendeddse. MOA:IsselectiveCOX2inhibitr(cxib+melxicam(atlwdse)) painmediatrse.gpg A/e Cmmn:N,dyspepsia,GIulceratinrbleeding, saltandfluidretentinhyperkalaemia,hypertensin headache,dizzy(c&a12)duet BP raisedliverenzymes infreq=hyperkalaemia,hf(cvevent),brnchspasm(asinhibtpgsmreaaloxlt) rare:hypersensitivity,acuterenalfailure(renalimpairment),blddyscrasia anaemiafrm GIbleeding GI:gastriculcer+GIbleeding impifccurstx:replacensaiw/paracetaml+giveppi(thencantestfrh.plyri afterulcerhealasitbecausingit) " ButifhavetcntusingNSAITx:givePPIegmeprazle20mgdrH2antag e.granitidine300mgd+uselwdse/leasttxicnsaie.gibuprfen200mgqid selectivensailessgis/ebutadvislstwhenusewiththernsai ibuprfenhaslessgis/ebutadvislstwhenusedatfulldse(400mg qid) CauseTinhibitCOXT1needfrPGsynthesistinhibitsecretinfgastricacidandprtect gastricmucsasnsai acid.als TXA2 bleedingrisk CV: riskfcveventsby BPe.gMI,strke(espmrebyselectiveNSAI)
10 Cause: renalfunctby GFRandrenalbldflw sdiumandfluidretentin BP c/i:hf renal:wrsenrenalimpairment Mnitr:GIbleeding/ulcere.gdarkstls,cffeegrainsvmit,dyspepsia,painincreaseespn mealsasincreasegastricacid BP,painlvls ElectrlyteK+ sayifpatientgtgibleeding/ulcer Iwuldmnitrfrdarkstls,FBPfrbldlss FBP,creatinineandLFTbefrestartingtreatment,andrepeatatleastnceayearduring cntinuedtreatment Interactintx:avidnsaiduseparacetaml.Ifisn tpssibleusethelwestdsepssiblenshrtest timerchangetalwerstrengthnsaie.gibuprfen UsewiththerNSAIs(incaspirin)addictiveeffectsgastricbleeding/ulcer, BP,impair renalfx anticagulant(inhibittxa2) riskfbleedingwiththeranticagulante.gwarfarin GIs/e OralCS gastriculceratin,dyspepsia alendrnate+nsais=alendrnatemayincreaseriskfgastriculceratinwithnsais; avidcmbrmnitrcarefully. renalfx NSAIs+diuretics=NSAIs(includingselectiveCOX2inhibitrs)reducerenalfxandmay reducediureticeffectandincreaseriskfnephrtxicity;mnitrbp,renalfunctinand weight;increasediureticdseaccrdinglyifnsaiusecanntbeavided.lwdseaspirin isunlikelytbeaprblem. TRIPLEWHAMMYdiuretic+ACEi/ATRA+NSAI GFRrenalfailure NSAIs+lithium=NSAIs(includingselectiveCOX2inhibitrs)mayreduce renallithium excretinandincreaseriskflithiumtxicity;txavidcmbunlessclsemnitring (mnitrlithiumcnc,renalfxandclinicaleffects;reducelithiumdseifnecessary)lw dseaspirinissafetuse. NSAIs+methtrexate=NSAIinducedreductininrenalfunctinreducesrenalexcretin fmethtrexateandmayincreaseriskftxicity(unlikelywithmethtrexatedses<20 mg/week);avidcmbinatinifmethtrexateisusedinantineplasticdses.lwdse aspirinmaybeused. Hyperkalaemia:NSAI+ptassium=NSAIcancausehyperkalaemiaduetcasuing renalfx.tx mnitrk+lvls BP_B_blckers,acei,CCB:asitcunteractstheireffectsby BP WrsenHTN,MI,HF Cunsel Ifyudevelpswllenankles,difficultyinbreathing,blackstlsrdarkcffeeclured vmit,stptakingthemedicineandtellyurdctrimmediately. nttakeaspirinfrpainreliefasitwillincreasetheriskfsideeffectswiththismedicine (label10a)dnttakemrethanneaspirineachdaywhilebeingtreatedwiththismed
Annex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationCase-based polymedication challenges
Case-based plymedicatin challenges Luise Mallet, B.Sc.Pharm., Pharm.D., BCGP, FESCP Prfesseure titulaire de clinique Faculty f Pharmacie, Université de Mntréal Clinical Pharmacist in Geriatrics McGill
More informationPolypharmacy in Geriatrics Home for the Summer Notre-Dame de Lourdes. Janine Grenier
Plypharmacy in Geriatrics Hme fr the Summer Ntre-Dame de Lurdes Janine Grenier 2016 Plypharmacy in the geriatric ppulatin is becming a cmmn cncern, with many patients being prescribed multiple medicatins
More informationDIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY
YOU AND YOUR BODY DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY kk WHY IS THIS LEAFLET FOR YOU? Pancreatic excrine insufficiency (PEI) is imprtant t understand in diabetes care due t the changing functins
More informationSTOPP START Toolkit. Supporting Medication Review. STOPP: Screening Tool of Older People s Potentially Inappropriate Prescriptions
STOPP START Tlkit Supprting Medicatin Review STOPP: Screening Tl f Older Peple s Ptentially Inapprpriate Prescriptins START: Screening Tl t Alert Dctrs t Right (i.e. apprpriate, indicated) Treatments Cntents
More informationWARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES
INDICATION FARYDAK (panbinstat) capsules, a histne deacetylase inhibitr, in cmbinatin with brtezmib and dexamethasne, is indicated fr the treatment f patients with multiple myelma wh have received at least
More informationMy Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)
My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made
More informationNBCHT Drug Information
NBCHT Drug Infrmatin USEFUL DRUG INFORMATION FOR COLON HYDROTHERAPISTS NSAIDs Nn-steridal anti-inflammatry Drugs are cmmnly prescribed fr treatment f pain and inflammatin eg. jint pain, arthritis, gut,
More informationPharmacology+for+Pharmacists+2+
Pharmacology+for+Pharmacists+2+ Contents'' Cardiovascular,disease, Page+134:+VASODILATORS,,,, Page+436:+Diuretics,, Page+639:+Inotropes,&,Antiarrhythmics,, Page+9311:+Antiplatelet,&,Thrombolytic,, Page+11313:+Anticoagulants,,
More informationIschemic heart disease (angina/chest pain)
Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember
More informationPackage leaflet: Information for the patient
1 Package leaflet: Infrmatin fr the patient Orxine 25 micrgram tablets Orxine 50 micrgram tablets Orxine 75 micrgram tablets Orxine 100 micrgram tablets Orxine 125 micrgram tablets Orxine 150 micrgram
More informationFamily Medicine Clinical Pharmacy Forum Vol. 3, Issue 5 (September/October 2007)
1 Family Medicine Clinical Pharmacy Frum Vl. 3, Issue 5 (September/Octber 2007) Family Medicine Clinical Pharmacy Frum is a brief bi-mnthly publicatin frm the Family Medicine clinical pharmacists distributed
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationNova Scotia Guidelines for Acute Coronary Syndromes (2008) QUICK REFERENCE MARCH Supported by unrestricted educational grants from:
Nva Sctia Guidelines fr Acute Crnary Syndrmes (2008) QUICK REFERENCE MARCH 2010 Supprted by unrestricted educatinal grants frm: Critical Pathways STEMI in the Emergency department EVALUATION Vital Signs
More informationLecture 9 PCL201 Drug Distribution
Lecture 9 PCL201 Drug Distributin Where d drugs distribute? Drug distributin (and ptentially cncentratin) will depend n bld flw and the physichemical prperties f the chemical Lipid and water slubility
More informationTrust Guideline for Treatment and prevention of Low Bone Mineral Density in Adults and Children with Cystic Fibrosis
Trust Guideline fr Treatment and preventin f Lw Bne Mineral Density in Adults and Children with Cystic Fibrsis A clinical guideline In: By: Fr: Key wrds: Written by: Supprted by: Assessed by: Apprved by
More informationSummary of Product Characteristics
Summary f Prduct Characteristics 1 NAME OF THE MEDICINAL PRODUCT 0.9% Sdium Chlride Intravenus Infusin Slutin 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sdium Chlride 9g per litre. Fr a full list f excipients,
More informationPharmacy Benefit Determination Policy
Plicy Subject: Osteprsis Agents Plicy Number: SHS PBD17 Categry: Rheumatlgy Plicy Type: Medical Pharmacy Department: Pharmacy Prduct (check all that apply): Grup HMO/POS Individual HMO/POS PPO ASO Dates:
More informationSOLUBLE URANIUM DEFINITION FOR REGULATORY COMPLIANCE
SOLUBLE URANIUM DEFINITION FOR REGULATORY COMPLIANCE Rland Benke, Ph.D., CHP (Center fr Nuclear Waste Regulatry Analyses) Tanya Oxenberg, Ph.D. (U.S. Nuclear Regulatry Cmmissin) James Webb (U.S. Nuclear
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationUnderstanding Your Total-Cholesterol-to-HDL Ratio
Understanding Yur Ttal-Chlesterl-t-HDL Rati Yur ttal-chlesterl-t-hdl rati is measured during a bld test called a lipid prfile. This wrksheet will help yu learn mre abut this rati. It will als help yu:
More informationCONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS
CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,
More informationThyroidectomy is the removal of the whole of, or part of the thyroid gland.
THYROIDECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that
More informationType 2 diabetes. Definition
Type 2 diabetes Definitin Type 2 diabetes, nce knwn as adult-nset r nninsulin-dependent diabetes, is a chrnic cnditin that affects the way yur bdy metablizes sugar (glucse), yur bdy's imprtant surce f
More informationMEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?
MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidmide) capsules What is the mst imprtant infrmatin I shuld knw abut REVLIMID? Befre yu begin taking REVLIMID, yu must read and agree t all f the instructins
More informationBP Thresholds for Medical Review
BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,
More informationPackage leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationGuidelines for the investigations & management of Vitamin B12 deficiency
Guidelines fr the investigatins & management f Vitamin B12 deficiency Backgrund We are frequently asked fr advice n the cause f a patient s vitamin B12 (cbalamin) deficiency and its management. Fr the
More informationPHARYNGO-OESOPHAGECTOMY
PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationFemale Athletic Triad See also Eating Disorders
Female Athletic Triad See als Eating Disrders Backgrund Eating disrders Amenrrhea Osteprsis 2. Cmbinatin f 3 medical cnditins Disrdered eating Amenrrhea Osteprsis Nt all pts have all 3 cmpnents f triad
More informationAsthma inhalers, medicines and treatments
Asthma inhalers, medicines and treatments Reliever inhalers Yur Emergency Rescue Reliever Everyne with asthma shuld ALWAYS carry a reliever (blue inhaler) inhaler at all the time s it s n hand in an emergency
More informationMedications. o Aspirin 100mg daily Risedronate 35mg weekly. o Clopidogrel 75mg daily Calcium/VitD 600mg/1000U
Medicatins Aspirin 100mg daily Risedrnate 35mg weekly Clpidgrel 75mg daily Calcium/VitD 600mg/1000U Atrvastatin 80mg ncte Allpurinl 100mg daily Diltiazem CD 240mg daily Laxatives daily Frusemide 80mg BD
More informationInternational Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1
Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,
More informationEvidence Dossier to support COPD formulary decision making and guideline development
Evidence Dssier t supprt COPD frmulary decisin making and guideline develpment Prescribing and adverse event reprting infrmatin can be fund n the final pages f this dcument. Anr and Ellipta Trademarks
More informationEvidence Dossier to support COPD formulary decision making and guideline development
Evidence Dssier t supprt COPD frmulary decisin making and guideline develpment Prescribing and adverse event reprting infrmatin can be fund n the final page f this dcument. Trelegy and Ellipta Trademarks
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationWhat s your diagnosis? Signlament: 11 y MC Maltese Mix. Presenting complaint: Pollakiuria with hematuria.
What s yur diagnsis? Signlament: 11 y MC Maltese Mix Presenting cmplaint: Pllakiuria with hematuria. Histry: Zippy presented with a 4 day histry f pllakiuria. Straining t urinate had nt been nted, hwever
More informationICD-10-CM Coding Basics Chapter Specifics
ICD-10-CM Cding Basics Chapter Specifics Chapter 15 Pregnancy, Childbirth and the Puerperium Vilma Smith, LVN, CPC, CCS Debra Bales, LVN, CPC Jnay Rischer, CPC 1 Rev. May 2015 ICD-10-CM Cnventins General
More informationDelaying Progression. Paul Drawz, MD, MHS, MS Assistant Professor of Medicine University of MN Minneapolis, MN
Delaying Prgressin Paul Drawz, MD, MHS, MS Assistant Prfessr f Medicine University f MN Minneaplis, MN Disclsure Paul Drawz, MD, MHS, MS has n financial relatinships with cmmercial interest(s). Learning
More informationPACKAGE LEAFLET INFORMATION FOR THE PATIENT
PACKAGE LEAFLET INFORMATION FOR THE PATIENT AMPICILLIN 125mg/5ml and 250mg/5ml ORAL SUSPENSION Please read all f this leaflet carefully befre yu start taking this medicine because it cntains imprtant infrmatin
More informationNew Patient Information Sheet PLEASE COMPLETE THIS ENTIRE FORM. Date of Appointment: / /
New Patient Infrmatin Sheet PLEASE COMPLETE THIS ENTIRE FORM The frm may seem lengthy but it is very imprtant t help us understand yur pain cmplaints. This will help us prvide yu with the highest level
More informationPrevention Checklist for Men
Page 1 f 5 Preventin Checklist fr Men A lt f prgress has been made in cancer research, but we still dn t understand exactly what causes mst cancers. We d knw that many factrs put us at higher risk fr different
More informationShared Care Protocol for the prescribing and monitoring of maintenance doses of azathioprine in Inflammatory Bowel Disease
Apprved by the Bedfrdshire and Lutn Jint Prescribing Cmmittee (JPC) December 2013, Review date December 2016 Bedfrdshire and Lutn Jint Prescribing Cmmittee Shared Care Prtcl fr the prescribing and mnitring
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationLow Molecular Weight Heparin Prescribing and Administration (Adults)
Clinical guideline Lw Mlecular Weight Heparin Prescribing and Administratin (Adults) The Natinal Patient Safety Agency issued guidance n ways f reducing dsing errrs when prescribing lw mlecular weight
More informationHow to become an AME Online
Hw t becme an AME Online 1. Check that yu meet the minimum technical requirements in rder t use the AME Online system: Operating System: Windws Vista (Service Pack 2) Windws 7 Windws 8, 8.1 Windws 10 Please
More informationMemory Screening Site s PROGRAM HANDBOOK
Memry Screening Site s PROGRAM HANDBOOK 866-232-8484 www.alzfdn.rg/memry-screening/ Table f Cntents Page 3 Page 5 Page 6 Page 7 Page 8 Page 10 Page 12 Page 13 All Abut the Natinal Memry Screening Prgram
More informationRituximab PROTOCOL FOR PAEDIATRIC RHEUMATOLOGY
Rituximab PROTOCOL FOR PAEDIATRIC RHEUMATOLOGY 1. Backgrund and indicatins Rituximab is a mnclnal antibdy that wrks by remving B-cells (a type f white bld cell that prduce antibdies). The aim f the B cell
More informationGeneric Immunosuppressants in the Specialist Area of Transplantation Consensus on Implications and Practical Recommendations
Dear Clleague Generic Immunsuppressants in the Specialist Area f Transplantatin Cnsensus n Implicatins and Practical Recmmendatins Executive Summary Slid-rgan transplants are the best pssible treatment
More informationRequest for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax
Request fr Prir Authrizatin fr Click here t enter text. Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 Updated: 05/2018 DMMA Apprved: 05/2018 All requests fr Intravenus
More informationCommon Pediatric Bone Diseases- Approach to Pathological Fractures
Cmmn Pediatric Bne Diseases- Apprach t Pathlgical Fractures 1. General Presentatin Teresa Liang Backgrund: It is nt uncmmn fr children t present with fractures after experiencing trauma. Hwever, children
More informationName of procedure: Removal of submandibular salivary gland
Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu
More informationCLINICAL PRACTICE GUIDELINE
Pages: 2 f 11 V. GUIDELINE: The fllwing guidelines are cnsistent with the 2018 Standards f Medical Care in Diabetes frm the American Diabetes Assciatin (ADA). Sme specificatins fr HEDIS measures f diabetes
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More informationEmergency Department Performance Measures
Emergency Department Perfrmance Measures ACEP Clinical Emergency Data Registry () ACEP Campaign Centers fr Medicare and Medicaid Services (CMS) Medicare Beneficiary Quality Imprvement Prject (MBQIP) ED
More informationThe policy was formulated through consultation between members of staff, governors, parents and pupils.
VALENCE PRIMARY SCHOOL Fd and Drink Plicy INTRODUCTION Valence Primary Schl is dedicated t prmting healthy lifestyles and prviding an envirnment that prmtes healthy eating and drinking, enabling pupils
More informationPost-Operative Spine Care
Pst-Operative Spine Care Activity: Yu will need t avid bending, lifting, twisting, and sudden mvements fr three weeks after surgery Sitting, specially if leaning frward, results in the greatest frces being
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential
More informationMedical History. Yes or No
Medical Histry Althugh dental persnnel primarily treat the area in and arund yur muth, yur muth is a part f yur entire bdy. Health prblems that yu may have, r medicatin that yu may be taking, culd have
More informationNew Exception Status Benefits
FEBRUARY 2019 Nva Sctia Frmulary Updates New Exceptin Status Benefits Prcysbi (cysteamine bitartrate) Nucala (meplizumab) Ocaliva (betichlic acid) Ravicti (glycerl phenylbutyrate) Taltz (ixekizumab) Criteria
More informationPART III: CONSUMER INFORMATION
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically
More informationCODING INFORMATION FOR
Indicatins a (CTCL) in patients ave received at least rall survival has nt ISTODAX (rmidepsin) fr injectin is indicated fr treatment f cutaneus T-cell lymphma (CTCL) in patients wh have received at least
More information3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?
3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:
More informationWHAT IS YOUR DIAGNOSIS?
WHAT IS YOUR DIAGNOSIS? A 10 year ld female neutered Brder Cllie was presented t the R(D)SVS Canine Medicine Service fr investigatin f lethargy, inappetance and weight lss. She had been inappetant fr apprximately
More informationActemra (tocilizumab) (Intravenous)
Actemra (tcilizumab) (Intravenus) Last Review Date: 06/01/2018 Date f Origin: 09/21/2010 Dcument Number: MODA-0002 Dates Reviewed: 12/2010, 03/2011, 05/2011, 06/2011, 09/2011, 12/2011, 03/2012, 06/2012,
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationHYPERTENSION AN OVERVIEW. Compiled by. Campbell M Gold (2008) CMG Archives --()-- IMPORTANT
HYPERTENSION AN OVERVIEW Cmpiled by Campbell M Gld (2008) CMG Archives http://campbellmgld.cm IMPORTANT The health infrmatin cntained herein is nt meant as a substitute fr advice frm yur physician, r ther
More informationApril 23, 2008 Information Sheet: Safety of BPA-derived Can Liners. Summary
April 23, 2008 Infrmatin Sheet: Safety f BPA-derived Can Liners Summary The use f bisphenl A (BPA)-derived epxy resins t make prtective catings fr metal fd and beverage packaging helps prvide safe, whlesme
More informationSymbol Key. Blue Box: Logic Logic related to skip patterns and question display parameters
In-persn Questinnaire TABLE OF CONTENTS: Intrductin/ SP Identity Verificatin (V 11 questins) Overall health General (G 2 questins) SF-8 (SF 8 questins) Cnditins and treatments Diagnses (D 10 questins)
More informationShared Care Protocol for the prescribing and monitoring of maintenance doses of azathioprine in Inflammatory Bowel Disease
Bedfrdshire and Lutn Jint Prescribing Cmmittee Shared Care Prtcl fr the prescribing and mnitring f maintenance dses f azathiprine in Inflammatry Bwel Disease This prtcl applies t patients under the care
More informationPackage leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate
Due t regulatry changes, the cntent f the fllwing Patient Infrmatin Leaflet may vary frm the ne fund in yur medicine pack. Please cmpare the 'Leaflet prepared/revised date' twards the end f the leaflet
More informationTick fever is a cattle disease caused by any one of the following blood parasites:
Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus
More informationWhere do we stand today?
Where d we stand tday? Nte by the United Natins Secretary-General transmitting the reprt f the Directr-General f WHO n the preventin and cntrl f NCDs (10 December 2013) Paragraph 43. Remarkable prgress
More informationNeonatal Jaundice Guideline
Nenatal Jaundice Guideline Guideline Number: 663 Supersedes: Classificatin Clinical Versin N: Date f EqIA: Apprved by: Date Apprved: Date made active: Review Date: 1 Obstetric Written Dcumentatin Review
More informationPackage leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationReference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57
Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical
More informationUse of sacubitril valsartan for the treatment of symptomatic chronic heart failure with reduced ejection fraction. Shared Care Protocol
Oxfrdshire Clinical Cmmissining Grup Use f sacubitril valsartan fr the treatment f symptmatic chrnic heart failure with reduced ejectin fractin. Shared Care Prtcl This prtcl prvides prescribing and mnitring
More informationEFFECT OF ADMINISTRATION OF ALENDRONATE SODIUM AND RETINOL ON THE MECHANICAL PROPERTIES OF THE FEMUR IN OVARIECTOMIZED RATS
Cpyright 2004 by Institute f Pharmaclgy Plish Academy f Sciences Plish Jurnal f Pharmaclgy Pl. J. Pharmacl., 2004, 56, 817 824 ISSN 1230-6002 EFFECT OF ADMINISTRATION OF ALENDRONATE SODIUM AND RETINOL
More informationANDREW BRAUNSTEIN. o MIT (3 degrees Computers / Management) o 25 years building Clinical Systems. o 6 Patents in Clinical Technologies
ANDREW BRAUNSTEIN MIT (3 degrees Cmputers / Management) 25 years building Clinical Systems ClinLgica Real-Time Clinical Rule Engine fr Predictive Analytics / Clinical Risk Management HealthWyse handheld
More informationCHEMOPREVENTION in BREAST CANCER
CHEMOPREVENTION in BREAST CANCER Ozlem Er, M.D. Assc Prf f Medical Onclgy ESMO Curse Essentials f Medical Onclgy Outline Risk Assessment Mlecular Targets ER psitive Breast Cancer Tamxifen Ralxifene Lasfxifene
More informationDIABETES POLICY Policy Statement & Commitments
Plicy Statement & Cmmitments Willaura Primary Schl Outside Schl Hurs Care Service 1 DIABETES POLICY 2018 Children with Diabetes are n mre likely t be sick than ther yung peple and can generally be expected
More informationYescarta (axicabtagene ciloleucel) (Intravenous)
Yescarta (axicabtagene cilleucel) (Intravenus) Last Review Date: 10/31/2017 Date f Origin: 10/31/2017 Dates Reviewed: 10/2017 Dcument Number: IC-0333 I. Length f Authrizatin Cverage will be prvided fr
More informationSummary of Product Characteristics. Summary of Product Characteristics. 1. Name of the Medicinal Product
1. Name f the Medicinal Prduct Tim-COMOD 0.1% eye drps Tim-COMOD 0.25% eye drps Tim-COMOD 0.5% eye drps 2. Qualitative and Quantitative Cmpsitin Active substance: Tim-COMOD 0.1% eye drps: 1 ml f eye drps
More informationSupplementary Online Content
Supplementary Online Content Kappos L, Li DKB, Stüve O, et al. Safety and efficacy of siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis: dose-blinded, randomized extension of the
More informationYear 1 MBChB Clinical Skills Session Blood Glucose Monitoring
Year 1 MBChB Clinical Skills Sessin Bld Glucse Mnitring Reviewed & ratified by: Dr V Taylr-Jnes, Cnsultant Anaesthetist Ms C Tierney, HARC Elements discussed with Ms Lesley Lamen, Diabetic Nurse Specialist
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationHead and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.
DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that
More informationCambridge Breast Unit Protocols for anticoagulant management prior to breast or axillary biopsies or excisions.
Prtcl CBU/POL/ JOINT POLICIES/008 Octber 2017 Prtcls fr anticagulant management prir t breast r axillary bipsies r excisins. 1. Scpe Fr use in the in bth screening and symptmatic breast services. 2. Purpse
More informationKadcyla (ado-trastuzumab emtansine) Document Number: IC-0092
Kadcyla (ad-trastuzumab emtansine) Dcument Number: IC-0092 Last Review Date: 2/6/2018 Date f Origin: 05/16/2013 Dates Reviewed: 7/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014, 5/2015, 8/2015,
More informationDiabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring)
Rule Categry: Medical ` Ref: N: 2013-MN-0012 Versin Cntrl: Versin N. 1.1 Effective Date: December 2013 Revisin Date: December 2014 Diabetes Mellitus Lab Tests (Screening, Diagnsis & Mnitring) Adjudicatin
More informationGlaucoma Interviews: Due Tuesday, May 22 nd
Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant
More informationMEDICATION GUIDE. (Interferon alfa-2b)
MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationFormulary and Prescribing Guidelines
SECTION 7: MANAGEMENT OF DEMENTIA Frmulary and Prescribing Guidelines 7.1 Apprved drugs fr use in cgnitive impairment f Alzheimer s disease Drug 3 Frmulatin 3 Dse 3 Licensed 4 Dnepezil Tablets 5 mg, 10
More informationKidney Transplantation, Hope to Life: Case Study Desperate Diseases Require Desperate Remedies
Human Jurnals Case Study September 2017 Vl.:10, Issue:2 All rights are reserved by Supriya et al. Kidney Transplantatin, Hpe t Life: Case Study Desperate Diseases Require Desperate Remedies Keywrds:Kidney
More information